Then, we performed survival analysis using the TCGA database and found that the high expression of four genes was significantly associated with shorter overall survival in GC patients, which were STAT3, TAOK1, PARVB, and PACS1 (Fig. 4B and Supplementary Fig. 3A–C). This evidence concerns the gene PACS1 and gastric cancer.